Why it is risky to be underweight on Indian Equities now?

With education from IIT/IIM, CFA charter and 25 years of industry experience, Harshad was the CIO Equities at JPMorgan Asset Management for over a decade and continued as the CIO Equities of Edelweiss Asset Management after the schemes changed hands in the year 2016. He’s responsible for long only equity mutual funds at Edelweiss Asset Management Limited. His resilience to come out of difficult times has been an inspiration to many. He has worked for 12 years on the sell side with various MNC brokerage firms and has been a rated research analyst by several large & prominent FIIs.

What will you learn in this webinar?

• How will vaccine development trigger continue to push markets higher
• Why Indian equities may continue to do well?
• What are the risks to our hypothesis?
• Advice for investors

Key learnings from this webinar

• Healthcare crisis needed a medical solution. Vaccine announcement is the beginning of the end to this healthcare crisis
• 3 companies have announced their vaccines but the challenge is of effective distribution
• Indian economy has bottomed out and is expected to improve sequentially
• Earnings growth trajectory of Indian corporates is also moving higher 
• The Government has passed long term reforms like the Agriculture Laws and the Labour Laws to lift potential growth rate
• There is a renewed focus on manufacturing through the Atmanirbhar Initiative & incentivizing investments.
• A divergence has been observed in the behaviour of the Foreign Investors & Domestic Investors. Foreign investors have been buying significantly in the Indian markets.
• The Indian equity market may continue to do well because of various reasons like the Indian economy moving past its worst and vaccine trigger.
• Investors need to reconsider the asset allocation in their portfolio since equity markets are expected to do well in the near future.
• There are certain risks to our hypothesis like subsequent infection waves, global risk-off events, Indian government going back on key reforms, global central banks reversing benign monetary policies & unknown and knowable risk like covid.